Characterization of Calcium Aluminate Cement Phases when in Contact with Simulated Body Fluid

Recent studies involving the use of calcium aluminate cement (CAC) as a biomaterial are based on commercial products. Improvements can be attained by investigating the properties of their crystalline phases in order to better design the material super(') s composition. Therefore, calcium alumin...

Full description

Saved in:
Bibliographic Details
Published inMaterials research (São Carlos, São Paulo, Brazil) Vol. 18; no. 2; pp. 382 - 389
Main Authors Oliveira, Ivone Regina de, Andrade, Talita Luana de, Parreira, Renata Martins, Jacobovitz, Marcos, Pandolfelli, Victor Carlos
Format Journal Article
LanguageEnglish
Published ABM, ABC, ABPol 01.04.2015
Associação Brasileira de Metalurgia e Materiais (ABM); Associação Brasileira de Cerâmica (ABC); Associação Brasileira de Polímeros (ABPol)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent studies involving the use of calcium aluminate cement (CAC) as a biomaterial are based on commercial products. Improvements can be attained by investigating the properties of their crystalline phases in order to better design the material super(') s composition. Therefore, calcium aluminate phase samples immersed in simulated body fluid (SBF) solutions prepared according to Kokubo's (KSBF) and Rigo's (RSBF) methodology had their pH evaluated. The surfaces of these samples were analyzed by SEM, EDX and XRD techniques. The treatment with KSBF did not favor the precipitation of calcium phosphate phases on the surface of CAC phases. On the other hand, in RSBF solution, the pH value attained was higher than for the KSBF one and magnesium phosphate was identified on the surface of CA, C sub(3) A and C sub(12) A sub(7) samples. Only for CA sub(2), the optimal precipitation condition was attained in RSBF and a surface layer of the hydroxyapatite was detected. Based on its ability of stimulating hydroxyapatite deposition in SBF and other properties, CA sub(2) can be eligible as the most suitable composition for biomedical purposes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1516-1439
1980-5373
1516-1439
1980-5373
DOI:10.1590/1516-1439.336714